| Cecilia Monique Rhodus, MD | |
|
6 E Chestnut St, Augusta, ME 04330-5758 | |
| (207) 623-6500 | |
| (207) 621-5504 |
| Full Name | Cecilia Monique Rhodus |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Developmental - Behavioral Pediatrics |
| Location | 6 E Chestnut St, Augusta, Maine |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699161059 | NPI | - | NPPES |
| Entity Name | Mainegeneral Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669423380 PECOS PAC ID: 1254245715 Enrollment ID: O20031118000718 |
News Archive
The GSMA today announced a first-of-its-kind clinical study for its mHealth Grand Tour in September 2013, which is designed to raise awareness of diabetes and promote the development and delivery of mHealth solutions in partnership with the International Diabetes Federation European Region (IDF Europe).
Robotic surgery for patients with early stage, oropharyngeal squamous cell cancer is associated with improved health outcomes, including better long-term survival, according to a Cedars-Sinai study published Thursday in JAMA Oncology.
Gerresheimer AG substantially increased earnings in the second quarter of financial year 2014."High-quality packaging for drugs and products enabling safe and easy self-medication continues to be increasingly in demand worldwide.
The National Eye Institute on Thursday said it will finance a two-year study comparing the effectiveness of Genentech's eye treatment Lucentis and cancer drug Avastin for treating wet age-related macular degeneration, the New York Times reports.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in INSPIRE 3, a Phase II clinical program evaluating the effect of repeated cycles of the company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in the treatment of chronically HIV-1 infected patients classified as Immunological Non-Responders (INR) after at least 24 months of highly active anti-retroviral therapy (HAART).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cecilia Monique Rhodus, MD 6 E Chestnut St, Augusta, ME 04330-5758 Ph: (207) 623-6500 | Cecilia Monique Rhodus, MD 6 E Chestnut St, Augusta, ME 04330-5758 Ph: (207) 623-6500 |
News Archive
The GSMA today announced a first-of-its-kind clinical study for its mHealth Grand Tour in September 2013, which is designed to raise awareness of diabetes and promote the development and delivery of mHealth solutions in partnership with the International Diabetes Federation European Region (IDF Europe).
Robotic surgery for patients with early stage, oropharyngeal squamous cell cancer is associated with improved health outcomes, including better long-term survival, according to a Cedars-Sinai study published Thursday in JAMA Oncology.
Gerresheimer AG substantially increased earnings in the second quarter of financial year 2014."High-quality packaging for drugs and products enabling safe and easy self-medication continues to be increasingly in demand worldwide.
The National Eye Institute on Thursday said it will finance a two-year study comparing the effectiveness of Genentech's eye treatment Lucentis and cancer drug Avastin for treating wet age-related macular degeneration, the New York Times reports.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in INSPIRE 3, a Phase II clinical program evaluating the effect of repeated cycles of the company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in the treatment of chronically HIV-1 infected patients classified as Immunological Non-Responders (INR) after at least 24 months of highly active anti-retroviral therapy (HAART).
› Verified 1 days ago
Sydney R Sewall, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 15 E Chestnut St, Augusta, ME 04330 Phone: 207-626-1561 Fax: 207-626-1849 | |
Stephen J Meister, MD, MHSA Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6 E Chestnut St, Augusta, ME 04330 Phone: 207-623-6500 Fax: 207-621-5504 | |
Dr. Erin Frances Flynn, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 35 Medical Center Pkwy, Augusta, ME 04330 Phone: 207-626-1000 | |
Kieran G Kammerer, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 6 E Chestnut St, Augusta, ME 04330 Phone: 207-623-2977 Fax: 207-626-9374 | |
Dr. Barbara A Crowley, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 263 Water St, Augusta, ME 04330 Phone: 207-623-2977 Fax: 207-626-9374 | |
Clota Snow, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 6 E Chestnut St, Augusta, ME 04330 Phone: 207-626-1000 | |
Dr. Musa Gokalp Bolkent, M.D.,M.P.H Pediatrics Medicare: Medicare Enrolled Practice Location: 6 E Chestnut St, Augusta, ME 04330 Phone: 207-623-2977 |